nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—colon cancer—ulcerative colitis	0.234	0.533	CtDrD
Methotrexate—ankylosing spondylitis—ulcerative colitis	0.205	0.467	CtDrD
Methotrexate—SLC46A1—Sulfasalazine—ulcerative colitis	0.0923	0.348	CbGbCtD
Methotrexate—ALB—ulcerative colitis	0.0617	0.512	CbGaD
Methotrexate—ABCB1—ulcerative colitis	0.0589	0.488	CbGaD
Methotrexate—AOX1—Mercaptopurine—ulcerative colitis	0.0393	0.148	CbGbCtD
Methotrexate—ABCC4—Mercaptopurine—ulcerative colitis	0.02	0.0753	CbGbCtD
Methotrexate—SLC22A8—Mercaptopurine—ulcerative colitis	0.0125	0.0471	CbGbCtD
Methotrexate—SLCO1B1—Sulfasalazine—ulcerative colitis	0.011	0.0416	CbGbCtD
Methotrexate—SLCO1A2—Prednisolone—ulcerative colitis	0.00988	0.0373	CbGbCtD
Methotrexate—ABCC2—Sulfasalazine—ulcerative colitis	0.00968	0.0365	CbGbCtD
Methotrexate—SLCO1A2—Hydrocortisone—ulcerative colitis	0.00937	0.0353	CbGbCtD
Methotrexate—SLCO1A2—Prednisone—ulcerative colitis	0.00933	0.0352	CbGbCtD
Methotrexate—ABCG2—Sulfasalazine—ulcerative colitis	0.00875	0.033	CbGbCtD
Methotrexate—ABCG2—Hydrocortisone—ulcerative colitis	0.00702	0.0265	CbGbCtD
Methotrexate—SLCO1A2—Dexamethasone—ulcerative colitis	0.00583	0.022	CbGbCtD
Methotrexate—ABCC2—Dexamethasone—ulcerative colitis	0.00483	0.0182	CbGbCtD
Methotrexate—ALB—Prednisone—ulcerative colitis	0.00482	0.0182	CbGbCtD
Methotrexate—ABCG2—Dexamethasone—ulcerative colitis	0.00437	0.0165	CbGbCtD
Methotrexate—ABCB1—Methylprednisolone—ulcerative colitis	0.00416	0.0157	CbGbCtD
Methotrexate—ABCC3—bile duct—ulcerative colitis	0.00319	0.102	CbGeAlD
Methotrexate—ABCB1—Betamethasone—ulcerative colitis	0.00271	0.0102	CbGbCtD
Methotrexate—ABCB1—Prednisolone—ulcerative colitis	0.00267	0.0101	CbGbCtD
Methotrexate—ABCC2—bile duct—ulcerative colitis	0.00255	0.0814	CbGeAlD
Methotrexate—ABCB1—Hydrocortisone—ulcerative colitis	0.00253	0.00955	CbGbCtD
Methotrexate—ABCB1—Prednisone—ulcerative colitis	0.00252	0.00952	CbGbCtD
Methotrexate—ABCC2—bile—ulcerative colitis	0.00196	0.0625	CbGeAlD
Methotrexate—ABCB1—Dexamethasone—ulcerative colitis	0.00157	0.00594	CbGbCtD
Methotrexate—FOLR1—epithelium—ulcerative colitis	0.00112	0.0357	CbGeAlD
Methotrexate—FOLR1—lymphoid tissue—ulcerative colitis	0.000863	0.0275	CbGeAlD
Methotrexate—SLC19A1—lymphoid tissue—ulcerative colitis	0.000757	0.0241	CbGeAlD
Methotrexate—SLC19A1—digestive system—ulcerative colitis	0.000748	0.0238	CbGeAlD
Methotrexate—GGH—smooth muscle tissue—ulcerative colitis	0.000718	0.0229	CbGeAlD
Methotrexate—ATIC—epithelium—ulcerative colitis	0.000633	0.0202	CbGeAlD
Methotrexate—ATIC—smooth muscle tissue—ulcerative colitis	0.00061	0.0195	CbGeAlD
Methotrexate—ABCC11—liver—ulcerative colitis	0.000609	0.0194	CbGeAlD
Methotrexate—SLC46A1—lymphoid tissue—ulcerative colitis	0.000583	0.0186	CbGeAlD
Methotrexate—SLC46A1—digestive system—ulcerative colitis	0.000576	0.0184	CbGeAlD
Methotrexate—GGH—digestive system—ulcerative colitis	0.000567	0.0181	CbGeAlD
Methotrexate—SLC19A1—liver—ulcerative colitis	0.000557	0.0178	CbGeAlD
Methotrexate—FPGS—lymphoid tissue—ulcerative colitis	0.000504	0.0161	CbGeAlD
Methotrexate—FPGS—digestive system—ulcerative colitis	0.000498	0.0159	CbGeAlD
Methotrexate—ATIC—lymphoid tissue—ulcerative colitis	0.000488	0.0156	CbGeAlD
Methotrexate—ATIC—digestive system—ulcerative colitis	0.000482	0.0154	CbGeAlD
Methotrexate—TYMS—Diflunisal—Olsalazine—ulcerative colitis	0.00045	0.254	CbGdCrCtD
Methotrexate—SLC46A1—liver—ulcerative colitis	0.000429	0.0137	CbGeAlD
Methotrexate—GGH—liver—ulcerative colitis	0.000422	0.0135	CbGeAlD
Methotrexate—TYMS—smooth muscle tissue—ulcerative colitis	0.000414	0.0132	CbGeAlD
Methotrexate—PGD—smooth muscle tissue—ulcerative colitis	0.000394	0.0126	CbGeAlD
Methotrexate—SLC22A11—digestive system—ulcerative colitis	0.000389	0.0124	CbGeAlD
Methotrexate—SLC16A1—epithelium—ulcerative colitis	0.000382	0.0122	CbGeAlD
Methotrexate—SLC22A7—digestive system—ulcerative colitis	0.00038	0.0121	CbGeAlD
Methotrexate—SLCO4C1—liver—ulcerative colitis	0.000374	0.0119	CbGeAlD
Methotrexate—FPGS—liver—ulcerative colitis	0.000371	0.0118	CbGeAlD
Methotrexate—SLCO1B3—liver—ulcerative colitis	0.000364	0.0116	CbGeAlD
Methotrexate—MTHFR—lymphoid tissue—ulcerative colitis	0.000362	0.0116	CbGeAlD
Methotrexate—ATIC—liver—ulcerative colitis	0.000359	0.0114	CbGeAlD
Methotrexate—MTHFR—digestive system—ulcerative colitis	0.000358	0.0114	CbGeAlD
Methotrexate—TYMS—lymphoid tissue—ulcerative colitis	0.000331	0.0106	CbGeAlD
Methotrexate—DHFR—lymphoid tissue—ulcerative colitis	0.000327	0.0104	CbGeAlD
Methotrexate—TYMS—digestive system—ulcerative colitis	0.000327	0.0104	CbGeAlD
Methotrexate—DHFR—digestive system—ulcerative colitis	0.000323	0.0103	CbGeAlD
Methotrexate—PGD—lymphoid tissue—ulcerative colitis	0.000315	0.01	CbGeAlD
Methotrexate—PGD—digestive system—ulcerative colitis	0.000311	0.00992	CbGeAlD
Methotrexate—SLC16A1—digestive system—ulcerative colitis	0.00029	0.00926	CbGeAlD
Methotrexate—SLC22A11—liver—ulcerative colitis	0.00029	0.00924	CbGeAlD
Methotrexate—SLC22A7—liver—ulcerative colitis	0.000283	0.00902	CbGeAlD
Methotrexate—SLCO1B1—digestive system—ulcerative colitis	0.000282	0.00901	CbGeAlD
Methotrexate—AOX1—digestive system—ulcerative colitis	0.000274	0.00874	CbGeAlD
Methotrexate—ABCC10—lymphoid tissue—ulcerative colitis	0.00027	0.00861	CbGeAlD
Methotrexate—ABCC3—digestive system—ulcerative colitis	0.000268	0.00855	CbGeAlD
Methotrexate—TYMS—Diflunisal—Mesalazine—ulcerative colitis	0.000267	0.151	CbGdCrCtD
Methotrexate—MTHFR—liver—ulcerative colitis	0.000267	0.00851	CbGeAlD
Methotrexate—ABCC10—digestive system—ulcerative colitis	0.000267	0.00851	CbGeAlD
Methotrexate—SLCO3A1—liver—ulcerative colitis	0.000262	0.00837	CbGeAlD
Methotrexate—TYMS—liver—ulcerative colitis	0.000243	0.00776	CbGeAlD
Methotrexate—DHFR—liver—ulcerative colitis	0.000241	0.00769	CbGeAlD
Methotrexate—PGD—liver—ulcerative colitis	0.000232	0.00739	CbGeAlD
Methotrexate—SLCO1A2—digestive system—ulcerative colitis	0.00023	0.00733	CbGeAlD
Methotrexate—ABCC4—digestive system—ulcerative colitis	0.000221	0.00706	CbGeAlD
Methotrexate—SLC16A1—liver—ulcerative colitis	0.000216	0.0069	CbGeAlD
Methotrexate—ABCC2—digestive system—ulcerative colitis	0.000214	0.00683	CbGeAlD
Methotrexate—SLCO1B1—liver—ulcerative colitis	0.00021	0.00671	CbGeAlD
Methotrexate—AOX1—liver—ulcerative colitis	0.000204	0.00651	CbGeAlD
Methotrexate—ABCC3—liver—ulcerative colitis	0.0002	0.00637	CbGeAlD
Methotrexate—ABCC10—liver—ulcerative colitis	0.000199	0.00634	CbGeAlD
Methotrexate—SLCO1A2—liver—ulcerative colitis	0.000171	0.00546	CbGeAlD
Methotrexate—ALB—liver—ulcerative colitis	0.00017	0.00543	CbGeAlD
Methotrexate—ABCC4—liver—ulcerative colitis	0.000165	0.00526	CbGeAlD
Methotrexate—ABCC2—liver—ulcerative colitis	0.00016	0.00509	CbGeAlD
Methotrexate—ABCC1—liver—ulcerative colitis	0.000141	0.00448	CbGeAlD
Methotrexate—ABCG2—liver—ulcerative colitis	0.000116	0.00371	CbGeAlD
Methotrexate—ABCB1—epithelium—ulcerative colitis	0.000101	0.00323	CbGeAlD
Methotrexate—ABCB1—lymphoid tissue—ulcerative colitis	7.8e-05	0.00249	CbGeAlD
Methotrexate—ABCB1—digestive system—ulcerative colitis	7.7e-05	0.00246	CbGeAlD
Methotrexate—ATIC—Levonorgestrel—Hydrocortisone—ulcerative colitis	6.69e-05	0.0377	CbGdCrCtD
Methotrexate—ABCB1—liver—ulcerative colitis	5.74e-05	0.00183	CbGeAlD
Methotrexate—TYMS—Clobetasol propionate—Budesonide—ulcerative colitis	4.82e-05	0.0272	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Budesonide—ulcerative colitis	4.76e-05	0.0268	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Budesonide—ulcerative colitis	4.71e-05	0.0266	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Budesonide—ulcerative colitis	4.34e-05	0.0245	CbGdCrCtD
Methotrexate—Headache—Budesonide—ulcerative colitis	3.07e-05	0.000324	CcSEcCtD
Methotrexate—Ill-defined disorder—Triamcinolone—ulcerative colitis	3.03e-05	0.00032	CcSEcCtD
Methotrexate—Ill-defined disorder—Methylprednisolone—ulcerative colitis	3.02e-05	0.00032	CcSEcCtD
Methotrexate—Alopecia—Betamethasone—ulcerative colitis	3.01e-05	0.000318	CcSEcCtD
Methotrexate—Alopecia—Dexamethasone—ulcerative colitis	3.01e-05	0.000318	CcSEcCtD
Methotrexate—Convulsion—Hydrocortisone—ulcerative colitis	3.01e-05	0.000318	CcSEcCtD
Methotrexate—Diarrhoea—Azathioprine—ulcerative colitis	2.99e-05	0.000316	CcSEcCtD
Methotrexate—Discomfort—Prednisolone—ulcerative colitis	2.99e-05	0.000316	CcSEcCtD
Methotrexate—Haemoglobin—Prednisone—ulcerative colitis	2.98e-05	0.000315	CcSEcCtD
Methotrexate—Haemorrhage—Prednisone—ulcerative colitis	2.96e-05	0.000313	CcSEcCtD
Methotrexate—Erythema—Dexamethasone—ulcerative colitis	2.96e-05	0.000313	CcSEcCtD
Methotrexate—Erythema—Betamethasone—ulcerative colitis	2.96e-05	0.000313	CcSEcCtD
Methotrexate—Myalgia—Hydrocortisone—ulcerative colitis	2.95e-05	0.000312	CcSEcCtD
Methotrexate—Malaise—Triamcinolone—ulcerative colitis	2.95e-05	0.000311	CcSEcCtD
Methotrexate—Malaise—Methylprednisolone—ulcerative colitis	2.94e-05	0.000311	CcSEcCtD
Methotrexate—Vertigo—Triamcinolone—ulcerative colitis	2.93e-05	0.00031	CcSEcCtD
Methotrexate—Hypersensitivity—Mesalazine—ulcerative colitis	2.93e-05	0.00031	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	2.93e-05	0.00031	CcSEcCtD
Methotrexate—Vertigo—Methylprednisolone—ulcerative colitis	2.93e-05	0.000309	CcSEcCtD
Methotrexate—Discomfort—Hydrocortisone—ulcerative colitis	2.92e-05	0.000308	CcSEcCtD
Methotrexate—Nausea—Budesonide—ulcerative colitis	2.91e-05	0.000307	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisolone—ulcerative colitis	2.9e-05	0.000306	CcSEcCtD
Methotrexate—Dizziness—Azathioprine—ulcerative colitis	2.89e-05	0.000305	CcSEcCtD
Methotrexate—Asthenia—Mesalazine—ulcerative colitis	2.86e-05	0.000302	CcSEcCtD
Methotrexate—Cough—Triamcinolone—ulcerative colitis	2.85e-05	0.000301	CcSEcCtD
Methotrexate—Anaphylactic shock—Hydrocortisone—ulcerative colitis	2.83e-05	0.000299	CcSEcCtD
Methotrexate—Convulsion—Triamcinolone—ulcerative colitis	2.83e-05	0.000299	CcSEcCtD
Methotrexate—Convulsion—Methylprednisolone—ulcerative colitis	2.82e-05	0.000298	CcSEcCtD
Methotrexate—Pruritus—Mesalazine—ulcerative colitis	2.82e-05	0.000298	CcSEcCtD
Methotrexate—Infection—Hydrocortisone—ulcerative colitis	2.81e-05	0.000297	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisolone—ulcerative colitis	2.8e-05	0.000296	CcSEcCtD
Methotrexate—Myalgia—Triamcinolone—ulcerative colitis	2.78e-05	0.000294	CcSEcCtD
Methotrexate—Vomiting—Azathioprine—ulcerative colitis	2.78e-05	0.000294	CcSEcCtD
Methotrexate—Nervous system disorder—Hydrocortisone—ulcerative colitis	2.78e-05	0.000293	CcSEcCtD
Methotrexate—Arthralgia—Methylprednisolone—ulcerative colitis	2.77e-05	0.000293	CcSEcCtD
Methotrexate—Myalgia—Methylprednisolone—ulcerative colitis	2.77e-05	0.000293	CcSEcCtD
Methotrexate—Eye disorder—Prednisone—ulcerative colitis	2.77e-05	0.000293	CcSEcCtD
Methotrexate—Rash—Azathioprine—ulcerative colitis	2.76e-05	0.000291	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	2.76e-05	0.000291	CcSEcCtD
Methotrexate—Dermatitis—Azathioprine—ulcerative colitis	2.75e-05	0.000291	CcSEcCtD
Methotrexate—Skin disorder—Hydrocortisone—ulcerative colitis	2.75e-05	0.000291	CcSEcCtD
Methotrexate—Ill-defined disorder—Dexamethasone—ulcerative colitis	2.75e-05	0.000291	CcSEcCtD
Methotrexate—Ill-defined disorder—Betamethasone—ulcerative colitis	2.75e-05	0.000291	CcSEcCtD
Methotrexate—Discomfort—Triamcinolone—ulcerative colitis	2.75e-05	0.00029	CcSEcCtD
Methotrexate—Discomfort—Methylprednisolone—ulcerative colitis	2.74e-05	0.00029	CcSEcCtD
Methotrexate—Headache—Azathioprine—ulcerative colitis	2.74e-05	0.000289	CcSEcCtD
Methotrexate—Hyperhidrosis—Hydrocortisone—ulcerative colitis	2.74e-05	0.000289	CcSEcCtD
Methotrexate—Diarrhoea—Mesalazine—ulcerative colitis	2.72e-05	0.000288	CcSEcCtD
Methotrexate—Anorexia—Hydrocortisone—ulcerative colitis	2.7e-05	0.000285	CcSEcCtD
Methotrexate—Angiopathy—Prednisone—ulcerative colitis	2.69e-05	0.000284	CcSEcCtD
Methotrexate—Confusional state—Methylprednisolone—ulcerative colitis	2.68e-05	0.000283	CcSEcCtD
Methotrexate—Immune system disorder—Prednisone—ulcerative colitis	2.68e-05	0.000283	CcSEcCtD
Methotrexate—Malaise—Betamethasone—ulcerative colitis	2.67e-05	0.000282	CcSEcCtD
Methotrexate—Malaise—Dexamethasone—ulcerative colitis	2.67e-05	0.000282	CcSEcCtD
Methotrexate—Anaphylactic shock—Triamcinolone—ulcerative colitis	2.67e-05	0.000282	CcSEcCtD
Methotrexate—Vertigo—Betamethasone—ulcerative colitis	2.66e-05	0.000281	CcSEcCtD
Methotrexate—Vertigo—Dexamethasone—ulcerative colitis	2.66e-05	0.000281	CcSEcCtD
Methotrexate—Anaphylactic shock—Methylprednisolone—ulcerative colitis	2.66e-05	0.000281	CcSEcCtD
Methotrexate—Infection—Triamcinolone—ulcerative colitis	2.65e-05	0.00028	CcSEcCtD
Methotrexate—Hypotension—Hydrocortisone—ulcerative colitis	2.65e-05	0.00028	CcSEcCtD
Methotrexate—Infection—Methylprednisolone—ulcerative colitis	2.64e-05	0.000279	CcSEcCtD
Methotrexate—Dizziness—Mesalazine—ulcerative colitis	2.63e-05	0.000278	CcSEcCtD
Methotrexate—Insomnia—Prednisolone—ulcerative colitis	2.62e-05	0.000277	CcSEcCtD
Methotrexate—Alopecia—Prednisone—ulcerative colitis	2.62e-05	0.000277	CcSEcCtD
Methotrexate—Nervous system disorder—Methylprednisolone—ulcerative colitis	2.61e-05	0.000276	CcSEcCtD
Methotrexate—Paraesthesia—Prednisolone—ulcerative colitis	2.6e-05	0.000275	CcSEcCtD
Methotrexate—Mental disorder—Prednisone—ulcerative colitis	2.6e-05	0.000275	CcSEcCtD
Methotrexate—Nausea—Azathioprine—ulcerative colitis	2.6e-05	0.000274	CcSEcCtD
Methotrexate—Skin disorder—Methylprednisolone—ulcerative colitis	2.58e-05	0.000273	CcSEcCtD
Methotrexate—Erythema—Prednisone—ulcerative colitis	2.58e-05	0.000273	CcSEcCtD
Methotrexate—Malnutrition—Prednisone—ulcerative colitis	2.58e-05	0.000273	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	2.58e-05	0.000273	CcSEcCtD
Methotrexate—Hyperhidrosis—Triamcinolone—ulcerative colitis	2.58e-05	0.000272	CcSEcCtD
Methotrexate—Hyperhidrosis—Methylprednisolone—ulcerative colitis	2.57e-05	0.000272	CcSEcCtD
Methotrexate—Convulsion—Dexamethasone—ulcerative colitis	2.57e-05	0.000271	CcSEcCtD
Methotrexate—Convulsion—Betamethasone—ulcerative colitis	2.57e-05	0.000271	CcSEcCtD
Methotrexate—Insomnia—Hydrocortisone—ulcerative colitis	2.56e-05	0.000271	CcSEcCtD
Methotrexate—Paraesthesia—Hydrocortisone—ulcerative colitis	2.54e-05	0.000269	CcSEcCtD
Methotrexate—Vomiting—Mesalazine—ulcerative colitis	2.53e-05	0.000268	CcSEcCtD
Methotrexate—Myalgia—Betamethasone—ulcerative colitis	2.52e-05	0.000267	CcSEcCtD
Methotrexate—Myalgia—Dexamethasone—ulcerative colitis	2.52e-05	0.000267	CcSEcCtD
Methotrexate—Rash—Mesalazine—ulcerative colitis	2.51e-05	0.000265	CcSEcCtD
Methotrexate—Dermatitis—Mesalazine—ulcerative colitis	2.51e-05	0.000265	CcSEcCtD
Methotrexate—Headache—Mesalazine—ulcerative colitis	2.49e-05	0.000264	CcSEcCtD
Methotrexate—Discomfort—Betamethasone—ulcerative colitis	2.49e-05	0.000263	CcSEcCtD
Methotrexate—Discomfort—Dexamethasone—ulcerative colitis	2.49e-05	0.000263	CcSEcCtD
Methotrexate—Dyspepsia—Hydrocortisone—ulcerative colitis	2.49e-05	0.000263	CcSEcCtD
Methotrexate—Hypotension—Methylprednisolone—ulcerative colitis	2.49e-05	0.000263	CcSEcCtD
Methotrexate—Pain—Prednisolone—ulcerative colitis	2.48e-05	0.000262	CcSEcCtD
Methotrexate—Decreased appetite—Hydrocortisone—ulcerative colitis	2.46e-05	0.00026	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	2.44e-05	0.000258	CcSEcCtD
Methotrexate—Fatigue—Hydrocortisone—ulcerative colitis	2.44e-05	0.000258	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Hydrocortisone—ulcerative colitis	2.44e-05	0.0137	CbGdCrCtD
Methotrexate—Vision blurred—Prednisone—ulcerative colitis	2.43e-05	0.000257	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	2.43e-05	0.000257	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	2.42e-05	0.000256	CcSEcCtD
Methotrexate—Pain—Hydrocortisone—ulcerative colitis	2.42e-05	0.000256	CcSEcCtD
Methotrexate—Anaphylactic shock—Betamethasone—ulcerative colitis	2.42e-05	0.000256	CcSEcCtD
Methotrexate—Anaphylactic shock—Dexamethasone—ulcerative colitis	2.42e-05	0.000256	CcSEcCtD
Methotrexate—Insomnia—Triamcinolone—ulcerative colitis	2.41e-05	0.000255	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Hydrocortisone—ulcerative colitis	2.41e-05	0.0136	CbGdCrCtD
Methotrexate—Insomnia—Methylprednisolone—ulcerative colitis	2.41e-05	0.000254	CcSEcCtD
Methotrexate—Infection—Dexamethasone—ulcerative colitis	2.4e-05	0.000254	CcSEcCtD
Methotrexate—Infection—Betamethasone—ulcerative colitis	2.4e-05	0.000254	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisone—ulcerative colitis	2.39e-05	0.000253	CcSEcCtD
Methotrexate—Paraesthesia—Triamcinolone—ulcerative colitis	2.39e-05	0.000253	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisolone—ulcerative colitis	2.39e-05	0.000252	CcSEcCtD
Methotrexate—Paraesthesia—Methylprednisolone—ulcerative colitis	2.39e-05	0.000252	CcSEcCtD
Methotrexate—Anaemia—Prednisone—ulcerative colitis	2.39e-05	0.000252	CcSEcCtD
Methotrexate—Dyspnoea—Triamcinolone—ulcerative colitis	2.38e-05	0.000251	CcSEcCtD
Methotrexate—Nervous system disorder—Betamethasone—ulcerative colitis	2.37e-05	0.000251	CcSEcCtD
Methotrexate—Nervous system disorder—Dexamethasone—ulcerative colitis	2.37e-05	0.000251	CcSEcCtD
Methotrexate—Thrombocytopenia—Betamethasone—ulcerative colitis	2.37e-05	0.00025	CcSEcCtD
Methotrexate—Thrombocytopenia—Dexamethasone—ulcerative colitis	2.37e-05	0.00025	CcSEcCtD
Methotrexate—Nausea—Mesalazine—ulcerative colitis	2.36e-05	0.00025	CcSEcCtD
Methotrexate—Dyspepsia—Triamcinolone—ulcerative colitis	2.35e-05	0.000248	CcSEcCtD
Methotrexate—Dyspepsia—Methylprednisolone—ulcerative colitis	2.34e-05	0.000247	CcSEcCtD
Methotrexate—Hyperhidrosis—Betamethasone—ulcerative colitis	2.34e-05	0.000247	CcSEcCtD
Methotrexate—Hyperhidrosis—Dexamethasone—ulcerative colitis	2.34e-05	0.000247	CcSEcCtD
Methotrexate—Feeling abnormal—Hydrocortisone—ulcerative colitis	2.33e-05	0.000247	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Methylprednisolone—ulcerative colitis	2.33e-05	0.0131	CbGdCrCtD
Methotrexate—Malaise—Prednisone—ulcerative colitis	2.33e-05	0.000246	CcSEcCtD
Methotrexate—Vertigo—Prednisone—ulcerative colitis	2.32e-05	0.000245	CcSEcCtD
Methotrexate—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	2.32e-05	0.000245	CcSEcCtD
Methotrexate—Anorexia—Betamethasone—ulcerative colitis	2.31e-05	0.000244	CcSEcCtD
Methotrexate—Anorexia—Dexamethasone—ulcerative colitis	2.31e-05	0.000244	CcSEcCtD
Methotrexate—Urticaria—Prednisolone—ulcerative colitis	2.3e-05	0.000243	CcSEcCtD
Methotrexate—Fatigue—Triamcinolone—ulcerative colitis	2.3e-05	0.000243	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Methylprednisolone—ulcerative colitis	2.3e-05	0.013	CbGdCrCtD
Methotrexate—Fatigue—Methylprednisolone—ulcerative colitis	2.29e-05	0.000242	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Dexamethasone—ulcerative colitis	2.29e-05	0.0129	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Betamethasone—ulcerative colitis	2.29e-05	0.0129	CbGdCrCtD
Methotrexate—Pain—Triamcinolone—ulcerative colitis	2.28e-05	0.000241	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Methylprednisolone—ulcerative colitis	2.27e-05	0.0128	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Dexamethasone—ulcerative colitis	2.26e-05	0.0128	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Betamethasone—ulcerative colitis	2.26e-05	0.0128	CbGdCrCtD
Methotrexate—Hypotension—Betamethasone—ulcerative colitis	2.26e-05	0.000239	CcSEcCtD
Methotrexate—Hypotension—Dexamethasone—ulcerative colitis	2.26e-05	0.000239	CcSEcCtD
Methotrexate—Urticaria—Hydrocortisone—ulcerative colitis	2.25e-05	0.000238	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Triamcinolone—ulcerative colitis	2.24e-05	0.0126	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Dexamethasone—ulcerative colitis	2.24e-05	0.0126	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Betamethasone—ulcerative colitis	2.24e-05	0.0126	CbGdCrCtD
Methotrexate—Abdominal pain—Hydrocortisone—ulcerative colitis	2.24e-05	0.000237	CcSEcCtD
Methotrexate—Body temperature increased—Hydrocortisone—ulcerative colitis	2.24e-05	0.000237	CcSEcCtD
Methotrexate—Convulsion—Prednisone—ulcerative colitis	2.24e-05	0.000236	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	2.22e-05	0.0125	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Triamcinolone—ulcerative colitis	2.21e-05	0.0125	CbGdCrCtD
Methotrexate—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	2.2e-05	0.000233	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	2.2e-05	0.000233	CcSEcCtD
Methotrexate—Arthralgia—Prednisone—ulcerative colitis	2.2e-05	0.000232	CcSEcCtD
Methotrexate—Myalgia—Prednisone—ulcerative colitis	2.2e-05	0.000232	CcSEcCtD
Methotrexate—Feeling abnormal—Triamcinolone—ulcerative colitis	2.2e-05	0.000232	CcSEcCtD
Methotrexate—Feeling abnormal—Methylprednisolone—ulcerative colitis	2.19e-05	0.000232	CcSEcCtD
Methotrexate—Insomnia—Dexamethasone—ulcerative colitis	2.19e-05	0.000231	CcSEcCtD
Methotrexate—Insomnia—Betamethasone—ulcerative colitis	2.19e-05	0.000231	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Betamethasone—ulcerative colitis	2.18e-05	0.0123	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Dexamethasone—ulcerative colitis	2.18e-05	0.0123	CbGdCrCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	2.18e-05	0.000231	CcSEcCtD
Methotrexate—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	2.17e-05	0.00023	CcSEcCtD
Methotrexate—Paraesthesia—Dexamethasone—ulcerative colitis	2.17e-05	0.00023	CcSEcCtD
Methotrexate—Paraesthesia—Betamethasone—ulcerative colitis	2.17e-05	0.00023	CcSEcCtD
Methotrexate—Discomfort—Prednisone—ulcerative colitis	2.17e-05	0.000229	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisolone—ulcerative colitis	2.14e-05	0.000226	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Triamcinolone—ulcerative colitis	2.13e-05	0.012	CbGdCrCtD
Methotrexate—Dyspepsia—Dexamethasone—ulcerative colitis	2.13e-05	0.000225	CcSEcCtD
Methotrexate—Dyspepsia—Betamethasone—ulcerative colitis	2.13e-05	0.000225	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisone—ulcerative colitis	2.12e-05	0.012	CbGdCrCtD
Methotrexate—Urticaria—Triamcinolone—ulcerative colitis	2.12e-05	0.000224	CcSEcCtD
Methotrexate—Urticaria—Methylprednisolone—ulcerative colitis	2.11e-05	0.000223	CcSEcCtD
Methotrexate—Body temperature increased—Triamcinolone—ulcerative colitis	2.11e-05	0.000223	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisone—ulcerative colitis	2.11e-05	0.000223	CcSEcCtD
Methotrexate—Abdominal pain—Methylprednisolone—ulcerative colitis	2.1e-05	0.000222	CcSEcCtD
Methotrexate—Decreased appetite—Dexamethasone—ulcerative colitis	2.1e-05	0.000222	CcSEcCtD
Methotrexate—Decreased appetite—Betamethasone—ulcerative colitis	2.1e-05	0.000222	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Prednisone—ulcerative colitis	2.1e-05	0.0118	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Methylprednisolone—ulcerative colitis	2.1e-05	0.0118	CbGdCrCtD
Methotrexate—Infection—Prednisone—ulcerative colitis	2.09e-05	0.000221	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Betamethasone—ulcerative colitis	2.09e-05	0.000221	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	2.09e-05	0.000221	CcSEcCtD
Methotrexate—Hypersensitivity—Hydrocortisone—ulcerative colitis	2.09e-05	0.00022	CcSEcCtD
Methotrexate—Fatigue—Betamethasone—ulcerative colitis	2.09e-05	0.00022	CcSEcCtD
Methotrexate—Fatigue—Dexamethasone—ulcerative colitis	2.09e-05	0.00022	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisone—ulcerative colitis	2.08e-05	0.0117	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisolone—ulcerative colitis	2.07e-05	0.0117	CbGdCrCtD
Methotrexate—Pain—Dexamethasone—ulcerative colitis	2.07e-05	0.000219	CcSEcCtD
Methotrexate—Pain—Betamethasone—ulcerative colitis	2.07e-05	0.000219	CcSEcCtD
Methotrexate—Nervous system disorder—Prednisone—ulcerative colitis	2.07e-05	0.000218	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Betamethasone—ulcerative colitis	2.06e-05	0.0116	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Dexamethasone—ulcerative colitis	2.06e-05	0.0116	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Prednisolone—ulcerative colitis	2.05e-05	0.0115	CbGdCrCtD
Methotrexate—Skin disorder—Prednisone—ulcerative colitis	2.05e-05	0.000216	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisone—ulcerative colitis	2.04e-05	0.000215	CcSEcCtD
Methotrexate—Asthenia—Hydrocortisone—ulcerative colitis	2.03e-05	0.000215	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisolone—ulcerative colitis	2.03e-05	0.0114	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Triamcinolone—ulcerative colitis	2.02e-05	0.0114	CbGdCrCtD
Methotrexate—Anorexia—Prednisone—ulcerative colitis	2.01e-05	0.000212	CcSEcCtD
Methotrexate—Pruritus—Hydrocortisone—ulcerative colitis	2e-05	0.000212	CcSEcCtD
Methotrexate—Feeling abnormal—Dexamethasone—ulcerative colitis	1.99e-05	0.000211	CcSEcCtD
Methotrexate—Feeling abnormal—Betamethasone—ulcerative colitis	1.99e-05	0.000211	CcSEcCtD
Methotrexate—Gastrointestinal pain—Betamethasone—ulcerative colitis	1.98e-05	0.000209	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dexamethasone—ulcerative colitis	1.98e-05	0.000209	CcSEcCtD
Methotrexate—Hypersensitivity—Triamcinolone—ulcerative colitis	1.96e-05	0.000208	CcSEcCtD
Methotrexate—Hypersensitivity—Methylprednisolone—ulcerative colitis	1.96e-05	0.000207	CcSEcCtD
Methotrexate—TYMS—Budesonide—Hydrocortisone—ulcerative colitis	1.95e-05	0.011	CbGdCrCtD
Methotrexate—Diarrhoea—Hydrocortisone—ulcerative colitis	1.94e-05	0.000205	CcSEcCtD
Methotrexate—Urticaria—Betamethasone—ulcerative colitis	1.92e-05	0.000203	CcSEcCtD
Methotrexate—Urticaria—Dexamethasone—ulcerative colitis	1.92e-05	0.000203	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Prednisone—ulcerative colitis	1.92e-05	0.000203	CcSEcCtD
Methotrexate—Dizziness—Prednisolone—ulcerative colitis	1.92e-05	0.000203	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisone—ulcerative colitis	1.91e-05	0.0108	CbGdCrCtD
Methotrexate—Asthenia—Triamcinolone—ulcerative colitis	1.91e-05	0.000202	CcSEcCtD
Methotrexate—Body temperature increased—Betamethasone—ulcerative colitis	1.91e-05	0.000202	CcSEcCtD
Methotrexate—Body temperature increased—Dexamethasone—ulcerative colitis	1.91e-05	0.000202	CcSEcCtD
Methotrexate—Abdominal pain—Dexamethasone—ulcerative colitis	1.91e-05	0.000202	CcSEcCtD
Methotrexate—Abdominal pain—Betamethasone—ulcerative colitis	1.91e-05	0.000202	CcSEcCtD
Methotrexate—Asthenia—Methylprednisolone—ulcerative colitis	1.91e-05	0.000202	CcSEcCtD
Methotrexate—Insomnia—Prednisone—ulcerative colitis	1.91e-05	0.000201	CcSEcCtD
Methotrexate—Paraesthesia—Prednisone—ulcerative colitis	1.89e-05	0.0002	CcSEcCtD
Methotrexate—Pruritus—Triamcinolone—ulcerative colitis	1.89e-05	0.000199	CcSEcCtD
Methotrexate—Pruritus—Methylprednisolone—ulcerative colitis	1.88e-05	0.000199	CcSEcCtD
Methotrexate—Dizziness—Hydrocortisone—ulcerative colitis	1.87e-05	0.000198	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisolone—ulcerative colitis	1.87e-05	0.0105	CbGdCrCtD
Methotrexate—TYMS—Danazol—Hydrocortisone—ulcerative colitis	1.87e-05	0.0105	CbGdCrCtD
Methotrexate—Dyspepsia—Prednisone—ulcerative colitis	1.85e-05	0.000196	CcSEcCtD
Methotrexate—TYMS—Budesonide—Methylprednisolone—ulcerative colitis	1.84e-05	0.0104	CbGdCrCtD
Methotrexate—Decreased appetite—Prednisone—ulcerative colitis	1.83e-05	0.000194	CcSEcCtD
Methotrexate—Rash—Prednisolone—ulcerative colitis	1.83e-05	0.000193	CcSEcCtD
Methotrexate—Dermatitis—Prednisolone—ulcerative colitis	1.83e-05	0.000193	CcSEcCtD
Methotrexate—Diarrhoea—Methylprednisolone—ulcerative colitis	1.82e-05	0.000192	CcSEcCtD
Methotrexate—Fatigue—Prednisone—ulcerative colitis	1.82e-05	0.000192	CcSEcCtD
Methotrexate—Headache—Prednisolone—ulcerative colitis	1.82e-05	0.000192	CcSEcCtD
Methotrexate—TYMS—Budesonide—Betamethasone—ulcerative colitis	1.81e-05	0.0102	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Dexamethasone—ulcerative colitis	1.81e-05	0.0102	CbGdCrCtD
Methotrexate—Vomiting—Hydrocortisone—ulcerative colitis	1.8e-05	0.00019	CcSEcCtD
Methotrexate—Rash—Hydrocortisone—ulcerative colitis	1.79e-05	0.000189	CcSEcCtD
Methotrexate—Dermatitis—Hydrocortisone—ulcerative colitis	1.78e-05	0.000188	CcSEcCtD
Methotrexate—Headache—Hydrocortisone—ulcerative colitis	1.77e-05	0.000187	CcSEcCtD
Methotrexate—TYMS—Budesonide—Triamcinolone—ulcerative colitis	1.77e-05	0.00997	CbGdCrCtD
Methotrexate—Dizziness—Triamcinolone—ulcerative colitis	1.76e-05	0.000186	CcSEcCtD
Methotrexate—Dizziness—Methylprednisolone—ulcerative colitis	1.76e-05	0.000186	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisone—ulcerative colitis	1.74e-05	0.000183	CcSEcCtD
Methotrexate—Asthenia—Betamethasone—ulcerative colitis	1.74e-05	0.000183	CcSEcCtD
Methotrexate—Asthenia—Dexamethasone—ulcerative colitis	1.74e-05	0.000183	CcSEcCtD
Methotrexate—Gastrointestinal pain—Prednisone—ulcerative colitis	1.72e-05	0.000182	CcSEcCtD
Methotrexate—Nausea—Prednisolone—ulcerative colitis	1.72e-05	0.000182	CcSEcCtD
Methotrexate—Pruritus—Betamethasone—ulcerative colitis	1.71e-05	0.000181	CcSEcCtD
Methotrexate—Pruritus—Dexamethasone—ulcerative colitis	1.71e-05	0.000181	CcSEcCtD
Methotrexate—Vomiting—Triamcinolone—ulcerative colitis	1.69e-05	0.000179	CcSEcCtD
Methotrexate—Vomiting—Methylprednisolone—ulcerative colitis	1.69e-05	0.000179	CcSEcCtD
Methotrexate—Nausea—Hydrocortisone—ulcerative colitis	1.68e-05	0.000178	CcSEcCtD
Methotrexate—Rash—Triamcinolone—ulcerative colitis	1.68e-05	0.000178	CcSEcCtD
Methotrexate—Dermatitis—Triamcinolone—ulcerative colitis	1.68e-05	0.000177	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisone—ulcerative colitis	1.68e-05	0.00946	CbGdCrCtD
Methotrexate—Rash—Methylprednisolone—ulcerative colitis	1.68e-05	0.000177	CcSEcCtD
Methotrexate—Dermatitis—Methylprednisolone—ulcerative colitis	1.68e-05	0.000177	CcSEcCtD
Methotrexate—Urticaria—Prednisone—ulcerative colitis	1.67e-05	0.000177	CcSEcCtD
Methotrexate—Headache—Triamcinolone—ulcerative colitis	1.67e-05	0.000176	CcSEcCtD
Methotrexate—Headache—Methylprednisolone—ulcerative colitis	1.67e-05	0.000176	CcSEcCtD
Methotrexate—Abdominal pain—Prednisone—ulcerative colitis	1.67e-05	0.000176	CcSEcCtD
Methotrexate—Body temperature increased—Prednisone—ulcerative colitis	1.67e-05	0.000176	CcSEcCtD
Methotrexate—Diarrhoea—Dexamethasone—ulcerative colitis	1.65e-05	0.000175	CcSEcCtD
Methotrexate—Diarrhoea—Betamethasone—ulcerative colitis	1.65e-05	0.000175	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisolone—ulcerative colitis	1.64e-05	0.00924	CbGdCrCtD
Methotrexate—TYMS—Danazol—Prednisone—ulcerative colitis	1.61e-05	0.00907	CbGdCrCtD
Methotrexate—Dizziness—Dexamethasone—ulcerative colitis	1.6e-05	0.000169	CcSEcCtD
Methotrexate—Dizziness—Betamethasone—ulcerative colitis	1.6e-05	0.000169	CcSEcCtD
Methotrexate—Nausea—Triamcinolone—ulcerative colitis	1.58e-05	0.000167	CcSEcCtD
Methotrexate—Nausea—Methylprednisolone—ulcerative colitis	1.58e-05	0.000167	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisone—ulcerative colitis	1.55e-05	0.000164	CcSEcCtD
Methotrexate—Vomiting—Betamethasone—ulcerative colitis	1.54e-05	0.000163	CcSEcCtD
Methotrexate—Vomiting—Dexamethasone—ulcerative colitis	1.54e-05	0.000163	CcSEcCtD
Methotrexate—Rash—Betamethasone—ulcerative colitis	1.53e-05	0.000161	CcSEcCtD
Methotrexate—Rash—Dexamethasone—ulcerative colitis	1.53e-05	0.000161	CcSEcCtD
Methotrexate—Dermatitis—Betamethasone—ulcerative colitis	1.52e-05	0.000161	CcSEcCtD
Methotrexate—Dermatitis—Dexamethasone—ulcerative colitis	1.52e-05	0.000161	CcSEcCtD
Methotrexate—Headache—Betamethasone—ulcerative colitis	1.52e-05	0.00016	CcSEcCtD
Methotrexate—Headache—Dexamethasone—ulcerative colitis	1.52e-05	0.00016	CcSEcCtD
Methotrexate—Asthenia—Prednisone—ulcerative colitis	1.51e-05	0.00016	CcSEcCtD
Methotrexate—Pruritus—Prednisone—ulcerative colitis	1.49e-05	0.000157	CcSEcCtD
Methotrexate—Diarrhoea—Prednisone—ulcerative colitis	1.44e-05	0.000152	CcSEcCtD
Methotrexate—Nausea—Betamethasone—ulcerative colitis	1.44e-05	0.000152	CcSEcCtD
Methotrexate—Nausea—Dexamethasone—ulcerative colitis	1.44e-05	0.000152	CcSEcCtD
Methotrexate—Dizziness—Prednisone—ulcerative colitis	1.39e-05	0.000147	CcSEcCtD
Methotrexate—Vomiting—Prednisone—ulcerative colitis	1.34e-05	0.000142	CcSEcCtD
Methotrexate—TYMS—Levonorgestrel—Hydrocortisone—ulcerative colitis	1.34e-05	0.00755	CbGdCrCtD
Methotrexate—Rash—Prednisone—ulcerative colitis	1.33e-05	0.00014	CcSEcCtD
Methotrexate—Dermatitis—Prednisone—ulcerative colitis	1.33e-05	0.00014	CcSEcCtD
Methotrexate—Headache—Prednisone—ulcerative colitis	1.32e-05	0.000139	CcSEcCtD
Methotrexate—Nausea—Prednisone—ulcerative colitis	1.25e-05	0.000132	CcSEcCtD
Methotrexate—ATIC—Metabolism—ALB—ulcerative colitis	1.09e-05	0.000229	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—ALB—ulcerative colitis	1.09e-05	0.000229	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	1.08e-05	0.000228	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL2—ulcerative colitis	1.08e-05	0.000227	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—DLD—ulcerative colitis	1.07e-05	0.000225	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—ulcerative colitis	1.06e-05	0.000224	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.06e-05	0.000223	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.05e-05	0.000222	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CALM3—ulcerative colitis	1.05e-05	0.000221	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.04e-05	0.00022	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—STAT3—ulcerative colitis	1.04e-05	0.000219	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—ulcerative colitis	1.04e-05	0.000218	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS1—ulcerative colitis	1.04e-05	0.000218	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	1.03e-05	0.000217	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.03e-05	0.000216	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CALM3—ulcerative colitis	1.03e-05	0.000216	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.02e-05	0.000216	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—ALB—ulcerative colitis	1.02e-05	0.000215	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—GNA12—ulcerative colitis	1.02e-05	0.000214	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—MMP1—ulcerative colitis	1e-05	0.000211	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ITGAL—ulcerative colitis	9.97e-06	0.00021	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.81e-06	0.000207	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—IL6—ulcerative colitis	9.74e-06	0.000205	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	9.74e-06	0.000205	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—TGFB1—ulcerative colitis	9.65e-06	0.000203	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—TGFB1—ulcerative colitis	9.51e-06	0.0002	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PTGS2—ulcerative colitis	9.5e-06	0.0002	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PTGS2—ulcerative colitis	9.5e-06	0.0002	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—JAK2—ulcerative colitis	9.48e-06	0.0002	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS1—ulcerative colitis	9.43e-06	0.000199	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PPARG—ulcerative colitis	9.41e-06	0.000198	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—JAK2—ulcerative colitis	9.39e-06	0.000198	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CALM3—ulcerative colitis	9.33e-06	0.000197	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	9.32e-06	0.000196	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	9.15e-06	0.000193	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—ulcerative colitis	9.13e-06	0.000192	CbGpPWpGaD
Methotrexate—MTHFR—Disease—ADCY5—ulcerative colitis	9.09e-06	0.000192	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.08e-06	0.000191	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.07e-06	0.000191	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	9.06e-06	0.000191	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS1—ulcerative colitis	9.04e-06	0.00019	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ALB—ulcerative colitis	9e-06	0.00019	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CD4—ulcerative colitis	8.9e-06	0.000188	CbGpPWpGaD
Methotrexate—AOX1—Disease—ADCY5—ulcerative colitis	8.88e-06	0.000187	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	8.87e-06	0.000187	CbGpPWpGaD
Methotrexate—FPGS—Disease—STAT3—ulcerative colitis	8.85e-06	0.000186	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTGS2—ulcerative colitis	8.84e-06	0.000186	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.82e-06	0.000186	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	8.76e-06	0.000185	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PPARG—ulcerative colitis	8.61e-06	0.000181	CbGpPWpGaD
Methotrexate—PGD—Disease—JAK2—ulcerative colitis	8.59e-06	0.000181	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.54e-06	0.00018	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC11A1—ulcerative colitis	8.52e-06	0.000179	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CALM3—ulcerative colitis	8.49e-06	0.000179	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ALB—ulcerative colitis	8.46e-06	0.000178	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	8.42e-06	0.000177	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—ulcerative colitis	8.36e-06	0.000176	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	8.33e-06	0.000175	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS1—ulcerative colitis	8.29e-06	0.000175	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.27e-06	0.000174	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	8.27e-06	0.000174	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IL2—ulcerative colitis	8.26e-06	0.000174	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	8.23e-06	0.000173	CbGpPWpGaD
Methotrexate—FPGS—Disease—TGFB1—ulcerative colitis	8.2e-06	0.000173	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.18e-06	0.000172	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.17e-06	0.000172	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.16e-06	0.000172	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ABCB1—ulcerative colitis	8.16e-06	0.000172	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.15e-06	0.000172	CbGpPWpGaD
Methotrexate—PGD—Disease—CD4—ulcerative colitis	8.14e-06	0.000172	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CALM3—ulcerative colitis	8.14e-06	0.000171	CbGpPWpGaD
Methotrexate—PGD—Disease—PTGS2—ulcerative colitis	8.08e-06	0.00017	CbGpPWpGaD
Methotrexate—DHFR—Disease—ADCY5—ulcerative colitis	8.08e-06	0.00017	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ABCB1—ulcerative colitis	7.97e-06	0.000168	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—ulcerative colitis	7.86e-06	0.000166	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	7.77e-06	0.000164	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.75e-06	0.000163	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ALB—ulcerative colitis	7.74e-06	0.000163	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	7.71e-06	0.000162	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MAML2—ulcerative colitis	7.65e-06	0.000161	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CHP1—ulcerative colitis	7.63e-06	0.000161	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ADCY5—ulcerative colitis	7.61e-06	0.00016	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ALB—ulcerative colitis	7.6e-06	0.00016	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS1—ulcerative colitis	7.48e-06	0.000158	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CALM3—ulcerative colitis	7.47e-06	0.000157	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ADCY5—ulcerative colitis	7.44e-06	0.000157	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTGS2—ulcerative colitis	7.4e-06	0.000156	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.36e-06	0.000155	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—ulcerative colitis	7.27e-06	0.000153	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ABCB1—ulcerative colitis	7.25e-06	0.000153	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	7.24e-06	0.000153	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	7.19e-06	0.000152	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.15e-06	0.000151	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.13e-06	0.00015	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.13e-06	0.00015	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CALM3—ulcerative colitis	7.07e-06	0.000149	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—JAK2—ulcerative colitis	7.06e-06	0.000149	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ALB—ulcerative colitis	7e-06	0.000147	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—STAT3—ulcerative colitis	6.89e-06	0.000145	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.86e-06	0.000145	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTGS2—ulcerative colitis	6.77e-06	0.000143	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ADCY5—ulcerative colitis	6.77e-06	0.000143	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CALM3—ulcerative colitis	6.74e-06	0.000142	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CHP1—ulcerative colitis	6.68e-06	0.000141	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	6.64e-06	0.00014	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ABCB1—ulcerative colitis	6.61e-06	0.000139	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DLD—ulcerative colitis	6.58e-06	0.000139	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.58e-06	0.000139	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS1—ulcerative colitis	6.51e-06	0.000137	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TGFB1—ulcerative colitis	6.45e-06	0.000136	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.44e-06	0.000136	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.41e-06	0.000135	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.41e-06	0.000135	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFB1—ulcerative colitis	6.39e-06	0.000135	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ABCB1—ulcerative colitis	6.33e-06	0.000133	CbGpPWpGaD
Methotrexate—PGD—Disease—STAT3—ulcerative colitis	6.31e-06	0.000133	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CALM3—ulcerative colitis	6.3e-06	0.000133	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	6.2e-06	0.000131	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—ulcerative colitis	6.18e-06	0.00013	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ADCY5—ulcerative colitis	6.16e-06	0.00013	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2—ulcerative colitis	6.16e-06	0.00013	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.09e-06	0.000128	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.09e-06	0.000128	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ADCY5—ulcerative colitis	5.9e-06	0.000124	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CALM3—ulcerative colitis	5.87e-06	0.000124	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS1—ulcerative colitis	5.86e-06	0.000124	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFB1—ulcerative colitis	5.84e-06	0.000123	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ABCB1—ulcerative colitis	5.81e-06	0.000122	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DLD—ulcerative colitis	5.77e-06	0.000122	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.77e-06	0.000121	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	5.75e-06	0.000121	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.73e-06	0.000121	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PPARG—ulcerative colitis	5.68e-06	0.00012	CbGpPWpGaD
Methotrexate—MTHFR—Disease—JAK2—ulcerative colitis	5.67e-06	0.000119	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.61e-06	0.000118	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS1—ulcerative colitis	5.57e-06	0.000117	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.55e-06	0.000117	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PPARG—ulcerative colitis	5.55e-06	0.000117	CbGpPWpGaD
Methotrexate—AOX1—Disease—JAK2—ulcerative colitis	5.54e-06	0.000117	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—ulcerative colitis	5.5e-06	0.000116	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.48e-06	0.000116	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.48e-06	0.000115	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ADCY5—ulcerative colitis	5.42e-06	0.000114	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	5.41e-06	0.000114	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD4—ulcerative colitis	5.37e-06	0.000113	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—ulcerative colitis	5.33e-06	0.000112	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—ulcerative colitis	5.31e-06	0.000112	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CALM3—ulcerative colitis	5.28e-06	0.000111	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD4—ulcerative colitis	5.25e-06	0.000111	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ABCB1—ulcerative colitis	5.24e-06	0.00011	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.21e-06	0.00011	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—ulcerative colitis	5.21e-06	0.00011	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS1—ulcerative colitis	5.16e-06	0.000109	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—ulcerative colitis	5.11e-06	0.000108	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PPARG—ulcerative colitis	5.05e-06	0.000106	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.04e-06	0.000106	CbGpPWpGaD
Methotrexate—DHFR—Disease—JAK2—ulcerative colitis	5.04e-06	0.000106	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CALM3—ulcerative colitis	5.02e-06	0.000106	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	4.99e-06	0.000105	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—ulcerative colitis	4.99e-06	0.000105	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ADCY5—ulcerative colitis	4.89e-06	0.000103	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.82e-06	0.000102	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—ulcerative colitis	4.82e-06	0.000101	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—ulcerative colitis	4.81e-06	0.000101	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—ulcerative colitis	4.8e-06	0.000101	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.79e-06	0.000101	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD4—ulcerative colitis	4.77e-06	0.000101	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.76e-06	0.0001	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—ulcerative colitis	4.74e-06	9.99e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CALM3—ulcerative colitis	4.64e-06	9.79e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARG—ulcerative colitis	4.6e-06	9.68e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ADCY5—ulcerative colitis	4.57e-06	9.63e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCB1—ulcerative colitis	4.56e-06	9.61e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—MMP1—ulcerative colitis	4.54e-06	9.56e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—ulcerative colitis	4.54e-06	9.56e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—ulcerative colitis	4.47e-06	9.41e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.44e-06	9.35e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—ulcerative colitis	4.4e-06	9.28e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARG—ulcerative colitis	4.4e-06	9.28e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—ulcerative colitis	4.36e-06	9.19e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ADCY5—ulcerative colitis	4.26e-06	8.97e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	4.22e-06	8.89e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—STAT3—ulcerative colitis	4.16e-06	8.77e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.15e-06	8.75e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—ulcerative colitis	4.13e-06	8.71e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCB1—ulcerative colitis	4.1e-06	8.65e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—STAT3—ulcerative colitis	4.06e-06	8.56e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARG—ulcerative colitis	4.04e-06	8.51e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—ulcerative colitis	3.97e-06	8.36e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—ulcerative colitis	3.96e-06	8.34e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—ulcerative colitis	3.96e-06	8.34e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCB1—ulcerative colitis	3.9e-06	8.22e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.89e-06	8.2e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.88e-06	8.17e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—ulcerative colitis	3.86e-06	8.13e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ADCY5—ulcerative colitis	3.83e-06	8.07e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—ulcerative colitis	3.77e-06	7.94e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—STAT3—ulcerative colitis	3.7e-06	7.79e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARG—ulcerative colitis	3.64e-06	7.68e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ADCY5—ulcerative colitis	3.64e-06	7.67e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—ulcerative colitis	3.63e-06	7.65e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—ulcerative colitis	3.62e-06	7.62e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCB1—ulcerative colitis	3.61e-06	7.61e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.48e-06	7.34e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—ulcerative colitis	3.46e-06	7.3e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—ulcerative colitis	3.43e-06	7.22e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.42e-06	7.21e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ADCY5—ulcerative colitis	3.37e-06	7.1e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—ulcerative colitis	3.28e-06	6.9e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—JAK2—ulcerative colitis	3.2e-06	6.74e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS1—ulcerative colitis	3.18e-06	6.71e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—ulcerative colitis	3.18e-06	6.7e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—ulcerative colitis	3.17e-06	6.69e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—ulcerative colitis	2.91e-06	6.12e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—ulcerative colitis	2.87e-06	6.04e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CALM3—ulcerative colitis	2.87e-06	6.04e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—ulcerative colitis	2.86e-06	6.02e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—ulcerative colitis	2.85e-06	6.01e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—JAK2—ulcerative colitis	2.85e-06	6.01e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—ulcerative colitis	2.84e-06	5.98e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS1—ulcerative colitis	2.79e-06	5.88e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2—ulcerative colitis	2.79e-06	5.88e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.74e-06	5.77e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—ulcerative colitis	2.71e-06	5.72e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD4—ulcerative colitis	2.7e-06	5.69e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—ulcerative colitis	2.68e-06	5.65e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.61e-06	5.5e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—ulcerative colitis	2.58e-06	5.44e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—ulcerative colitis	2.57e-06	5.41e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—ulcerative colitis	2.51e-06	5.29e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CALM3—ulcerative colitis	2.51e-06	5.29e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—ulcerative colitis	2.5e-06	5.26e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—ulcerative colitis	2.44e-06	5.14e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—ulcerative colitis	2.26e-06	4.76e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—ulcerative colitis	2.25e-06	4.73e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCB1—ulcerative colitis	2.23e-06	4.7e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—ulcerative colitis	2.17e-06	4.58e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—ulcerative colitis	2.13e-06	4.5e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—STAT3—ulcerative colitis	2.09e-06	4.41e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ADCY5—ulcerative colitis	2.08e-06	4.38e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—ulcerative colitis	1.98e-06	4.17e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—ulcerative colitis	1.94e-06	4.09e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.82e-06	3.84e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—ulcerative colitis	1.79e-06	3.77e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—ulcerative colitis	1.55e-06	3.27e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—ulcerative colitis	1.46e-06	3.08e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—ulcerative colitis	1.36e-06	2.86e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—ulcerative colitis	1.22e-06	2.57e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—ulcerative colitis	1.22e-06	2.57e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—ulcerative colitis	1.07e-06	2.25e-05	CbGpPWpGaD
